FDA


depakote,birth defect, birth defects,generic, generic drug, granuflo, actos, AVANDIA, BIRTH DEFECT, BIRTH INJURY, FOSAMAX, ANDROGEL, LOW T, RISPERDAL, TRASYLOL, ACCUTANE, ACTOS, DEFECTIVE DRUG, DRUG INJURY, DEFECTIVE DRUG INJURY, YAZ, YASMIN, GIANVI, OCELLA, ZOLOFT, FEN PHEN, PAXIL,DEPAKOTE,topmax, celexa, lexapro, xarelto
Recently, the Food and Drug Administration proposed amending its regulations in connection with drug labels to revise and clarify procedures for an approved drug or biological product to change the product labeling to reflect certain types of newly acquired information in advance of FDA’s review of the change.  The basic […]

Drug Labels



Recently, the FDA issued a nuvaring label change.  Apparently, a nuvaring label change was approved by the FDA Center for Drug Evaluation and Research (CDER) on October 2013.  The nuvaring label change was related to Thromboembolic Disorders and Other Vascular Problems.  In particular, the nuvaring label change stated the following: […]

Nuvaring Label Change



depakote,birth defect, birth defects,generic, generic drug, granuflo, actos, AVANDIA, BIRTH DEFECT, BIRTH INJURY, FOSAMAX, ANDROGEL, LOW T, RISPERDAL, TRASYLOL, ACCUTANE, ACTOS, DEFECTIVE DRUG, DRUG INJURY, DEFECTIVE DRUG INJURY, YAZ, YASMIN, GIANVI, OCELLA, ZOLOFT, FEN PHEN, PAXIL,DEPAKOTE,topmax, celexa, lexapro, xarelto
FDA, Topamax, Cleft Lip & Birth Defect: Back in March 2011, the FDA review of topamax was a startling revelation to many of its users.  The FDA review of topamax published in 2011 concerning the use of TOPAMAX® during pregnancy stated that if you take Topamax during pregnancy, your baby […]

FDA, Topamax, Cleft Lip & Birth Defect